Jindal IVF Advances Fertility Education with 21st Annual ART Update in Chandigarh

▴ Jindal IVF
Jindal IVF, a leading institute in Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF) in North India, successfully hosted the 21st edition of its flagship ART Update CME on 31st August 2025 in Chandigarh.

Hello! If you're looking for high-quality genericmedications, fast delivery and excellent customer service, ourstore is the right choice for you. With over 20 years of onlineexperience, we guarantee safe, effective products that are alwaysin stock. Delivery within 48 hours, free shipping from $200, and 100% money-back guarantee if your order doesn't arrive on time.

👉 Order now at BestCheapPills and discover exclusive discounts for registeredcustomers!

Chandigarh, 3rd September 2025: Jindal IVF, a leading institute in Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF) in North India, successfully hosted the 21st edition of its flagship ART Update CME on 31st August 2025 in Chandigarh. Themed around “Innovations in Infertility Management and Future of ART,” the event marked another significant step in advancing fertility education and strengthening clinical practice for doctors across the region.

The conference featured interactive lectures, expert-led discussions, and paper presentations, workshops with practical demonstrations, attracting enthusiastic participation from gynaecologists, embryologists, endocrinologists, urologists, and young fertility specialists.

The 21st ART Update featured a diverse range of sessions addressing critical aspects of infertility care and advancements in reproductive medicine. The program opened with a session on the Management of Endometriosis-related Infertility using Non-Invasive EFI Scoring, presented by Dr. Umesh Jindal. The deliberations continued with Prof. (Col.) Pankaj Talwar (President IFS), who shared valuable insights on Management Strategies in Male Infertility based on the Aphrodite Classification. The program also featured an engaging panel discussion on “Add-ons in IVF Lab: Evidence-Based Practice,” moderated by Dr. Lavleen Sodhi and Dr. Sheetal Jindal, offering practical perspectives on optimizing outcomes in assisted reproduction.

The scientific program also featured two parallel workshops designed to enhance practical learning. One explored the role and preparation of PRP in ART with demonstrations and discussions, while the other focused on fine-tuning IVF stimulation, addressing ovarian stimulation strategies, embryo transfer choices, and challenges in frozen cycles. Together, the sessions provided participants with actionable clinical insights.

All senior members of the Jindal IVF faculty, including Dr. Umesh Jindal and Dr. Sheetal Jindal, actively participated in the scientific sessions and engaged with the medical fraternity. The event also included oral paper presentations by young doctors, emphasizing Jindal IVF’s commitment to nurturing future leaders in reproductive medicine.

Reflecting on the success of the event, Dr. Sheetal Jindal, Senior Consultant and IVF-PGT Specialist at Jindal IVF, said, “The 21st ART Update once again reaffirmed our mission of creating a collaborative platform for advancing fertility care. By integrating the latest research, clinical experience, and patient-centred approaches, we aim to empower practitioners with knowledge that translates into better patient outcomes. Such academic exchanges are essential in preparing healthcare providers for the evolving challenges in reproductive medicine.”

Now in its 21st year, the ART Update has become a credible academic platform for evidence-based learning in infertility management, fertility preservation, and reproductive endocrinology. The conference also addressed misconceptions about IVF and fertility treatments, ensuring that practitioners remain aligned with global standards in ART.

With a legacy of 12,000+ successful deliveries, 20,000+ IUI procedures, and 15,000+ IVF cycles, along with innovations like PGT-HLA for Thalassemia major patients and advanced management of high-risk pregnancies, Jindal IVF continues to lead reproductive healthcare in North India, spreading hope and transforming lives.

 

About Jindal IVF:

Established in 1989 by Dr. Umesh Jindal, Jindal IVF is a renowned institute in Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF) in Northern India. With over 30 years of experience in IVF, it is the largest standalone IVF centre North of Delhi, offering comprehensive services in infertility treatment, general gynaecology, surgery, maternity, mental health counselling, and paediatrics. The team comprises 14 consultants and 3 embryologists, making it one of the largest specialized centres in the region. Jindal IVF prides itself on being the leader in infertility cases in Tricity, serving patients not only in Chandigarh but also in the surrounding areas of Punjab, Haryana, and Himachal Pradesh. Despite increasing competition, the commitment to quality remains unwavering as the institution strives to remain at the foremost provider of IVF and gynaecological services in the region, guided by its vision to transform lives by spreading the joy of parenthood. To know more, please visit: https://www.ivfchandigarh.com/

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026